Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion

Figure 1

(a) At baseline, the transthoracic echocardiogram demonstrates moderately depressed LV function (LVEF-40%) with significant concentric and septal LV hypertrophy (LV mass 367 grams, IVSd-2.1 cm, PWT-1.5 cm, RWT-0.67). (b) There is further evidence of elevated filling pressures. There is left atrial enlargement (LA dimension-4.6 cm), mildly elevated estimated right ventricular systolic pressure (RVSP36 mmHg), and restrictive filling on mitral inflow Doppler (E/A-2.3, deceleration time 190 milliseconds).

(a)

(b)